PI-88 News
Most Popular PI-88 Story
Progen lung cancer therapy flunks Phase II
Progen Pharmaceuticals disappointed its investors with news this morning that its experimental therapy, PI-88, failed a mid-stage trial for lung cancer. The trial, which combined the experimental Read more...
Latest Headlines
- July 24, 2008
- September 24, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
